AK Medical (HKG:1789) expects net profit to increase more than 20% in the first half from a year earlier, according to a Tuesday Hong Kong bourse filing.
The company also expects revenue to rise about 10%, with overseas revenue increasing about 40% from the corresponding period of 2025.
AK Medical attributed the expected growth to rapid increases in overseas sales and sales of intelligent devices.